Arzneimittel - Open Access .click

Results 41 to 50 of about 30,414 (210)

PA-Kontaminationen in Arzneipflanzen: Vorkommen, Grenzwerte und Maßnahmen

Journal für Kulturpflanzen, 2020
Seit mehreren Jahren wird eine mögliche Kontamination von Arzneipflanzen mit pyrrolizidinalkaloid-haltigen Beikräutern diskutiert. Die Erkenntnisse über ein solches Risiko hat die Anbauer und Lieferanten pflanzlicher Drogen und die Hersteller von ...
Barbara Steinhoff
doaj +1 more source

A natural barrier: tick‐repellent potential of a spruce‐derived volatile blend against Hyalomma excavatum and Ixodes ricinus

Pest Management Science, Volume 82, Issue 2, Page 1481-1491, February 2026.
Both active and passive questing ticks, Hyalomma excavatum and Ixodes ricinus, were assessed for behavioural responses to two novel plant‐derived repellent volatile organic compound blends. Both tick species were repelled by the products, and both novo blends were significantly more repellent than currently available commercial products.
Martyn J. Wood +5 more
wiley +1 more source

Die Festbetragsregelung im AMNOG-Markt – ein Blick aus der Praxis

Monitor Versorgungsforschung
Dieser Beitrag untersucht die praktische Umsetzung der Schnittstelle zwischen den Preisregulierungsinstrumenten AMNOG und Festbetrag im deutschen Arzneimittelmarkt von 2011 bis Juli 2024. Dabei werden drei typische Fallkonstellationen der Verknüpfung der
Susann Lukat, Dr. Ulrike Götting
doaj +1 more source

Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms

Allergy, Volume 81, Issue 2, Page 427-453, February 2026.
The Allergic Rhinitis and its Impact on Asthma (ARIA) group is working on the 2024–2025 update of its guidelines for the management of allergic rhinitis (ARIA 2024–2025). The ARIA 2024–2025‐EAACI guidelines will follow GRADE methodology and will incorporate evidence from different sources, including systematic reviews and meta‐analyses, mHealth data ...
Jean Bousquet +230 more
wiley +1 more source

Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study

Pulmonary Therapy, 2018
Introduction Intra-seasonal start of treatment with the SQ® grass sublingual immunotherapy(SLIT) tablet (GRAZAX®, ALK, Denmark) has been previously demonstrated to be well-tolerated. The objective of our study was to investigate the tolerability of intra-
Jan-Alexander Schwab +3 more
doaj +1 more source

Regulatorische Handhabung der selektiven Erstattung von Arzneimitteln in den ausgewählten Ländern England, Niederlande, Frankreich und Schweden [PDF]

, 2015
[Einleitung] Im Rahmen des AMNOG wurde die Preisbildung für patentgeschützte Arzneimittel und damit die Erstattung durch die GKV neu geregelt. Seit 2011 wird in einer Verhandlung festgelegt, wie viel die Krankenkassen ab dem 13.
Bauer, Cosima +5 more
core

Response to High‐Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic Effect

European Journal of Pain, Volume 30, Issue 1, January 2026.
ABSTRACT Background Topical high‐dose capsaicin treatment is a recommended therapy for localised neuropathic pain with good tolerability and no identified drug interactions. However, it is not effective for every patient. So far, few parameters in patient history have been identified as predictors for response to capsaicin treatment.
Manon Sendel +11 more
wiley +1 more source

Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients

Scientific Reports, 2023
With the changing epidemiology of COVID-19 and its impact on our daily lives, there is still an unmet need of COVID-19 therapies treating early infections to prevent progression.
Jens Peter Klussmann +26 more
doaj +1 more source

S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieempfehlungen und Monitoring

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 122-139, January 2026.
Zusammenfassung Der vorliegende Teil 1 der Aktualisierung der S3‐Leitlinie zur Therapie der Psoriasis vulgaris umfasst die Abschnitte „Therapieempfehlungen“, „Therapieziele“ sowie die „Monitoringempfehlungen“ zu den Therapien. Die Grundlage bildet die aktuelle Cochrane‐Netzwerkmetaanalyse, deren Ergebnisse ebenfalls dargestellt werden.
Alexander Nast +25 more
wiley +1 more source

Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults

ERJ Open Research, 2019
Introduction The results of a clinical trial published in 2016 showed the efficacy of ivy leaves dry extract EA 575 versus placebo in the treatment of patients suffering from acute cough.
Axel Schaefer +4 more
doaj +1 more source

medicine
amnog
pflanzliche arzneimittel

adhd
hippocampus
nutzenbewertung